Company intelligence / Profile preview

Nutropy

Évry / Paris area, Île-de-France, Francenutropy.com ↗

Ownership: Private
Employees: ~50
Development stage: Preclinical

Overview

Nutropy has developed a precision fermentation process using genetically engineered yeast to produce bioidentical milk proteins and fatty acids. These are combined with plant-based ingredients to create a "cheeseable milk" solution for B2B partners. Early feedback from industry stakeholders has been positive regarding taste and texture compared to conventional cheese. Products have not yet reached the commercial market as of early 2025.

Modalities: Recombinant proteinPrecision fermentation
Industry: Non-Drug Biotech

Partnerships

Collaborations with industrial dairy partnerspartnership with IBISBA’s Transnational Access under Horizon 2020 EU program for access to biotech research platformscollaborations with French cheese specialists and research institutes.

Beyond the preview

Go deeper on Nutropy.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nutropy.

Explore the full profile